Gastric Helicobacter pylori infection associated with risk of diabetes mellitus, but not prediabetes

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 10, 2014, Pages 1794-1799

  Yang, Gi Hua ^a   Wu, Jin Shang ^a,b   Yang, Yi Ching ^a,b   Huang, Ying Hsiang ^a   Lu, Feng Hwa ^a,b   Chang, Chih Jen ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Diabetes mellitus; Helicobacter pylori; Prediabetic state

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIGESTIVE TRACT ENDOSCOPY; EDUCATIONAL STATUS; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIFESTYLE; MALE; MICROBIOLOGY; MULTIVARIATE ANALYSIS; OBESITY; PREDIABETIC STATE; PREVALENCE; RISK; TAIWAN;

AGE FACTORS; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EDUCATIONAL STATUS; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIFE STYLE; MALE; MULTIVARIATE ANALYSIS; OBESITY; PREDIABETIC STATE; PREVALENCE; RISK; TAIWAN;

EID: 84906759656     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12617     Document Type: Article

References (40)

1. Kanjilal S, Gregg EW, Cheng YJ etal. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch. Intern. Med. 2006; 166: 2348-2355.
2. Williams ED, Tapp RJ, Magliano DJ, Shaw JE, Zimmet PZ, Oldenburg BF. Health behaviours, socioeconomic status and diabetes incidence: the Australian Diabetes Obesity and Lifestyle Study (AusDiab). Diabetologia 2010; 53: 2538-2545.
3. Nabipour I, Vahdat K, Jafari SM, Pazoki R, Sanjdideh Z. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: the Persian Gulf Healthy Heart Study. Cardiovasc. Diabetol. 2006; 5: 25.
4. Simanek AM, Dowd JB, Aiello AE. Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. Int. J. Epidemiol. 2009; 38: 775-787.
5. Banic M, Franceschi F, Babic Z, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2012; 17 (Suppl. 1): 49-55.
6. Quatrini M, Boarino V, Ghidoni A, Baldassarri AR, Bianchi PA, Bardella MT. Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J. Clin. Gastroenterol. 2001; 32: 215-217.
7. Gulcelik NE, Kaya E, Demirbas B etal. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J. Endocrinol. Invest. 2005; 28: 214-217.
8. Devrajani BR, Shah SZ, Soomro AA, Devrajani T. Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: a hospital based case-control study. Int. J. Diabetes Dev. Ctries. 2010; 30: 22-26.
9. Jeon CY, Haan MN, Cheng C etal. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care 2012; 35: 520-525.
10. Ko GT, Chan FK, Chan WB etal. Helicobacter pylori infection in Chinese subjects with type 2 diabetes. Endocr. Res. 2001; 27: 171-177.
11. Xia HH, Talley NJ, Kam EP, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am. J. Gastroenterol. 2001; 96: 1039-1046.
12. Anastasios R, Goritsas C, Papamihail C, Trigidou R, Garzonis P, Ferti A. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur. J. Intern. Med. 2002; 13: 376-379.
13. Demir M, Gokturk HS, Ozturk NA, Kulaksizoglu M, Serin E, Yilmaz U. Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig. Dis. Sci. 2008; 53: 2646-2649.
14. Lutsey PL, Pankow JS, Bertoni AG, Szklo M, Folsom AR. Serological evidence of infections and Type 2 diabetes: the MultiEthnic Study of Atherosclerosis. Diabet. Med. 2009; 26: 149-152.
15. Peach HG, Barnett NE. Helicobacter pylori infection and fasting plasma glucose concentration. J. Clin. Pathol. 2001; 54: 466-469.
16. Kyriazanos ID, Sfiniadakis I, Dimakos P, Gizaris V, Datsakis K, Dafnopoulou A. Impact of body mass index on fasting blood glucose concentration among Helicobater pylori carriers. Dig. Dis. 2003; 21: 262-265.
17. Bruden DL, Bruce MG, Miernyk KM etal. Diagnostic accuracy of tests for Helicobacter pylori in an Alaska Native population. World J. Gastroenterol. 2011; 17: 4682-4688.
18. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33 (Suppl. 1): S11-61.
19. Manco M, Putignani L, Bottazzo GF. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr. Rev. 2010; 31: 817-844.
20. Wellen KE. Inflammation, stress, and diabetes. J. Clin. Invest. 2005; 115: 1111-1119.
21. Nweneka CV, Prentice AM. Helicobacter pylori infection and circulating ghrelin levels-a systematic review. BMC Gastroenterol. 2011; 11: 7.
22. Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546-2553.
23. Temelkova-Kurktschiev T, Henkel E, Koehler C, Karrei K, Hanefeld M. Subclinical inflammation in newly detected Type II diabetes and impaired glucose tolerance. Diabetologia 2002; 45: 151.
24. Sabanayagam C, Shankar A, Lim SC, Lee J, Tai ES, Wong TY. Serum C-reactive protein level and prediabetes in two Asian populations. Diabetologia 2011; 54: 767-775.
25. Papaioannou I, Patterson M, Twigg GL etal. Lack of association between impaired glucose tolerance and appetite regulating hormones in patients with obstructive sleep apnea. J. Clin. Sleep Med. 2011; 7: 486-492.
26. Bennett NR, Boyne MS, Cooper RS etal. Impact of adiponectin and ghrelin on incident glucose intolerance and on weight change. Clin. Endocrinol. (Oxf) 2009; 70: 408-414.
27. Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N. Engl. J. Med. 2000; 342: 905-912.
28. Sun Z, Zheng L, Xu C etal. Prevalence of diabetes and impaired fasting glucose in hypertensive adults in rural China. Acta Cardiol. 2009; 64: 351-356.
29. Meisinger C, Doring A, Heier M. Blood pressure and risk of type 2 diabetes mellitus in men and women from the general population: the Monitoring Trends and Determinants on Cardiovascular Diseases/Cooperative Health Research in the Region of Augsburg Cohort Study. J. Hypertens. 2008; 26: 1809-1815.
30. Sowers JR. Insulin resistance and hypertension. Am. J. Physiol. Heart Circ. Physiol. 2004; 286: H1597-1602.
31. Yang SJ, Hwang SY, Choi HY etal. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J. Clin. Endocrinol. Metab. 2011; 96: E1325-1329.
32. Karam JG, McFarlane SI. Update on the prevention of type 2 diabetes. Curr. Diab. Rep. 2011; 11: 56-63.
33. Tirosh A, Shai I, Bitzur R etal. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care 2008; 31: 2032-2037.
34. Lu FH, Yang YC, Wu JS, Wu CH, Chang CJ. A population-based study of the prevalence and associated factors of diabetes mellitus in southern Taiwan. Diabet. Med. 1998; 15: 564-572.
35. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care 1993; 16: 157-177.
36. Rodriguez-Moran M, Guerrero-Romero F, Aradillas-Garcia C etal. Obesity and family history of diabetes as risk factors of impaired fasting glucose: implications for the early detection of prediabetes. Pediatr. Diabetes 2010; 11: 331-336.
37. DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003; 26: 61-69.
38. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am. J. Gastroenterol. 2007; 102: 1808-1825.
39. Cutler AF, Prasad VM, Santogade P. Four-year trends in Helicobacter pylori IgG serology following successful eradication. Am. J. Med. 1998; 105: 18-20.
40. Osaki T, Mabe K, Hanawa T, Kamiya S. Urease-positive bacteria in the stomach induce a false-positive reaction in a urea breath test for diagnosis of Helicobacter pylori infection. J. Med. Microbiol. 2008; 57: 814-819.